advanced glycation end-products |
AGEs |
bone mineral density |
BMD |
bone morphogenetic proteins |
BMPs |
Camurati–Engelman Disease |
CED |
endoplasmic reticulum |
ER |
extracellular matrix |
ECM |
heat shock protein 47 |
Hsp47 |
latency-associated protein |
LAP |
lipoprotein receptor-related protein 5 |
LRP 5 |
Loeys–Dietz syndrome |
LDS |
lysyl hydroxylase 2 |
LH2 |
Marfan Syndrome |
MFS |
matrix metalloproteinases |
MMPs |
mitogen-activated protein kinase |
MAPK |
noncollagenous proteins |
NCPs |
osteocalcin |
OC |
osteogenesis imperfecta |
OI |
osteonectin |
ON |
osteopontin |
OPN |
osteoporosis-pseudoglioma syndrome |
OPPG |
osteoprotegerin |
OPG |
ovariectomized |
OVX |
parathyroid hormone |
PTH |
receptor activator of nuclear factor κβ ligand |
RANKL |
runt-related transcription factor 2 |
Runx2 |
single nucleotide polimorfism |
SNP |
transforming growth factor beta |
TGF-β |
tissue inhibitors of metalloproteinases |
TIMPs |
wingless-type mouse mammary tumor virus integration site family |
Wnt |